Koo

I do hear you. However, my point is that if management had done it's job to begin with, we would not be talking about this today. When the Hepa deal was announced, DM touted that the company had a fully funded Phase III trial. Why are we short of cash?  This will probably be the last opportunity they get to go to the well - IMHO they better load up for the journey. So, if the trial board extends the number of MACE events to 375 will they be ready? or is it deja vu all over again? 

Chicagoest